FDA approves Johns Hopkins University plasma therapy trial

FDA approves Johns Hopkins University plasma therapy trial

Johns Hopkins University Bloomberg School of Public Health’s Dr. Arturo Casadevall on efforts to treat COVID-19 with blood plasma.

Leave a Reply